Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SNSE | US
-0.04
-7.69%
Healthcare
Biotechnology
30/06/2024
17/10/2024
0.42
0.49
0.49
0.42
Sensei Biotherapeutics Inc. an immuno-oncology company engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101 SNS-103 and SNS-102 monoclonal antibodies which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals Inc. Sensei Biotherapeutics Inc. was incorporated in 1999 and is headquartered in Rockville Maryland.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
68.7%1 month
106.6%3 months
82.3%6 months
117.5%-
-
0.23
0.10
0.08
1.36
-
-
-30.98M
10.66M
10.66M
-
-
-
-
-45.17
2.70
1.51
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.10
Range1M
0.18
Range3M
0.35
Rel. volume
4.04
Price X volume
165.86K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Jaguar Health Inc | JAGX | Biotechnology | 1.23 | 11.37M | 0.00% | 0.26 | 176.14% |
Common Stock | ADXN | Biotechnology | 10.6 | 11.33M | 0.47% | n/a | 0.25% |
Immuron Limited | IMRN | Biotechnology | 1.97 | 11.22M | -1.99% | n/a | 1.37% |
Evogene Ltd | EVGN | Biotechnology | 2.14 | 11.15M | -16.08% | n/a | 26.41% |
TransCode Therapeutics Inc. Common Stock | RNAZ | Biotechnology | 0.599 | 10.78M | -11.79% | 0.00 | 17.19% |
RedHill Biopharma Ltd | RDHL | Biotechnology | 8.205 | 10.51M | -3.36% | n/a | 65.80% |
Alterity Therapeutics Limited | ATHE | Biotechnology | 1.2 | 10.49M | -4.00% | n/a | 1.15% |
GlycoMimetics Inc | GLYC | Biotechnology | 0.1585 | 10.22M | 1.02% | n/a | 2.24% |
SNTI | SNTI | Biotechnology | 2.15 | 9.84M | -1.83% | n/a | 80.96% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.36 | 0.53 | Expensive |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 0.23 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 82.31 | 72.92 | Par |
Debt to Equity | 0.10 | -1.24 | Expensive |
Debt to Assets | 0.08 | 0.25 | Cheaper |
Market Cap | 10.66M | 3.78B | Emerging |